Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally.

Journal

Cancer discovery
ISSN: 2159-8290
Titre abrégé: Cancer Discov
Pays: United States
ID NLM: 101561693

Informations de publication

Date de publication:
12 Jun 2024
Historique:
received: 15 03 2024
revised: 26 04 2024
accepted: 07 05 2024
medline: 13 6 2024
pubmed: 13 6 2024
entrez: 13 6 2024
Statut: aheadofprint

Résumé

Cancer Core Europe brings together the expertise, resources, and interests of seven leading cancer institutes committed to leveraging collective innovation and collaboration in precision oncology. Through targeted efforts addressing key medical challenges in cancer and partnerships with multiple stakeholders, the consortium seeks to advance cancer research and enhance equitable patient care.

Identifiants

DOI: 10.1158/2159-8290.CD-24-0377 PMID: 38870393
pubmed: 38870393
pii: 745892
doi: 10.1158/2159-8290.CD-24-0377
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

OF1-OF7

Informations de copyright

©2024 American Association for Cancer Research.

Auteurs

Javier Carmona (J)

Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
ORCID: 0000-0001-7904-8493

Elena Chavarria (E)

Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
ORCID: 0009-0008-3182-8309

Kate Donoghue (K)

Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
ORCID: 0000-0002-8715-9828

Christina von Gertten (C)

Karolinska Institutet, Stockholm, Sweden.
ORCID: 0009-0003-0029-3237

Petra Oberrauch (P)

German Cancer Research Center (DKFZ), Heidelberg, Germany.
National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
ORCID: 0009-0005-9730-790X

Emma Pailler (E)

Gustave Roussy, Villejuif, France.
ORCID: 0000-0002-7329-7429

Giovanni Scoazec (G)

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
ORCID: 0009-0001-3187-3176

Ruud Weijer (R)

Netherlands Cancer Institute, Amsterdam, the Netherlands.
ORCID: 0009-0002-2733-4468

Judith Balmaña (J)

Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
ORCID: 0000-0002-0762-6415

Irene Brana (I)

Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
ORCID: 0000-0002-1068-9601

Cinzia Brunelli (C)

Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
ORCID: 0000-0003-3905-1289

Suzette Delaloge (S)

Interception Programme, Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
ORCID: 0000-0003-2106-9165

Marc Deloger (M)

Gustave Roussy, Villejuif, France.
ORCID: 0000-0002-6352-101X

Pierre Delpy (P)

Federated Information Systems, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Complex Medical Informatics, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.
German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.
ORCID: 0009-0002-8442-8719

Ingemar Ernberg (I)

Department of Microbiology, Tumor and Cell Biology (MTC), Cancer Center Karolinska (CCK) & Biomedicum. Karolinska Institutet, Stockholm, Sweden.
ORCID: 0000-0001-6518-1648

Rebecca C Fitzgerald (RC)

Department of Oncology, Early Cancer Institute, University of Cambridge, Cambridge, United Kingdom.
ORCID: 0000-0002-3434-3568

Elena Garralda (E)

Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
ORCID: 0000-0002-4412-7842

Martin Lablans (M)

Federated Information Systems, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Complex Medical Informatics, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.
German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.
ORCID: 0000-0003-1880-5555

Janne Lëhtio (J)

Department of Oncology and Pathology, Karolinska Institutet, SciLifeLab, Solna, Sweden.
Karolinska University Hospital, Stockholm, Sweden.
ORCID: 0000-0002-8100-9562

Carlos Lopez (C)

Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
ORCID: 0009-0007-0847-324X

Maialen Fernández (M)

Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
ORCID: 0009-0008-2713-2309

Rosalba Miceli (R)

Unit of Biostatistics for Clinical Research, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
ORCID: 0000-0003-0954-375X

Paolo Nuciforo (P)

Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
ORCID: 0000-0003-1380-0990

Raquel Perez-Lopez (R)

Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
ORCID: 0000-0002-9176-0130

Elena Provenzano (E)

Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
ORCID: 0000-0003-3345-3965

Marjanka K Schmidt (MK)

Division of Molecular Pathology, NKI Center for Early Diagnostics, Lead Early Detection Research Theme, Netherlands Cancer Institute, Amsterdam, the Netherlands.
ORCID: 0000-0002-2228-429X

Cesar Serrano (C)

Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
ORCID: 0000-0003-1416-8739

Neeltje Steeghs (N)

Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
ORCID: 0000-0003-2989-2279

David Tamborero (D)

Department of Oncology and Pathology, Karolinska Institutet, SciLifeLab, Solna, Sweden.
Karolinska University Hospital, Stockholm, Sweden.
ORCID: 0000-0002-7218-2806

Valtteri Wirta (V)

Department of Microbiology, Tumor and Cell Biology, Karolinska Instiutet, Stockholm, Sweden.
Genomic Medicine Center Karolinska, Karolinska University Hospital, Stockholm, Sweden.
ORCID: 0000-0003-3811-5439

Richard D Baird (RD)

Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
ORCID: 0000-0001-7071-6483

Karen Barker (K)

Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
ORCID: 0009-0002-3334-5518

Fabrice Barlesi (F)

Gustave Roussy, Villejuif, France.
Paris Saclay University, Villejuif, France.
ORCID: 0000-0001-5793-3539

Michael Baumann (M)

German Cancer Research Center (DKFZ), Heidelberg, Germany.
National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
German Cancer Consortium (DKTK), Heidelberg, Germany.
ORCID: 0000-0002-9340-974X

Jonas Bergh (J)

Karolinska Institutet, Stockholm, Sweden.
Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Solna, Sweden.
ORCID: 0000-0001-5526-1847

Filippo de Braud (F)

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
ORCID: 0000-0003-0103-730X

Karim Fizazi (K)

Gustave Roussy, Villejuif, France.
ORCID: 0000-0002-6068-9474

Stefan Fröhling (S)

German Cancer Research Center (DKFZ), Heidelberg, Germany.
National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
German Cancer Consortium (DKTK), Heidelberg, Germany.
Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.
ORCID: 0000-0001-7907-4595

Alejandro Piris-Giménez (A)

Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
ORCID: 0000-0002-7768-3722

Kenneth Seamon (K)

Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
ORCID: 0009-0002-5418-9614

Michiel S Van der Heijden (MS)

Netherlands Cancer Institute, Amsterdam, the Netherlands.
ORCID: 0000-0002-4407-7881

Wilbert Zwart (W)

Netherlands Cancer Institute, Amsterdam, the Netherlands.
Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.
ORCID: 0000-0002-9823-7289

Josep Tabernero (J)

Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
ORCID: 0000-0002-2495-8139

Classifications MeSH